These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23049546)

  • 61. Optimal Timing of Feeding After Endoscopic Hemostasis in Patients With Peptic Ulcer Bleeding: A Randomized, Noninferiority Trial (CRIS KCT0001019).
    Gong EJ; Lee SJ; Jun BG; Seo HI; Park JK; Han KH; Kim YD; Jeong WJ; Cheon GJ; Park SY
    Am J Gastroenterol; 2020 Apr; 115(4):548-554. PubMed ID: 32205642
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparison of adjuvant therapies by an H2-receptor antagonist and a proton pump inhibitor after endoscopic treatment in hemostatic management of bleeding gastroduodenal ulcers.
    Sakurada T; Kawashima J; Ariyama S; Kani K; Takabayashi H; Ohno S; Kato S; Yakabi K
    Dig Endosc; 2012 Mar; 24(2):93-9. PubMed ID: 22348833
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A comparison of oral omeprazole and intravenous cimetidine in reducing complications of duodenal peptic ulcer.
    Khoshbaten M; Fattahi E; Naderi N; Khaleghian F; Rezailashkajani M
    BMC Gastroenterol; 2006 Jan; 6():2. PubMed ID: 16403233
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of omeprazole on the outcome of endoscopically treated bleeding peptic ulcers. Randomized double-blind placebo-controlled multicentre study.
    Schaffalitzky de Muckadell OB; Havelund T; Harling H; Boesby S; Snel P; Vreeburg EM; Eriksson S; Fernström P; Hasselgren G
    Scand J Gastroenterol; 1997 Apr; 32(4):320-7. PubMed ID: 9140153
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Omeprazole as adjuvant therapy to endoscopic combination injection sclerotherapy for treating bleeding peptic ulcer.
    Javid G; Masoodi I; Zargar SA; Khan BA; Yatoo GN; Shah AH; Gulzar GM; Sodhi JS
    Am J Med; 2001 Sep; 111(4):280-4. PubMed ID: 11566458
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
    Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
    Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Treatment and prognosis in peptic ulcer bleeding.
    Laursen SB
    Dan Med J; 2014 Jan; 61(1):B4797. PubMed ID: 24547604
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cost-effectiveness analysis of high-dose omeprazole infusion as adjuvant therapy to endoscopic treatment of bleeding peptic ulcer.
    Lee KK; You JH; Wong IC; Kwong SK; Lau JY; Chan TY; Lau JT; Leung WY; Sung JJ; Chung SS
    Gastrointest Endosc; 2003 Feb; 57(2):160-4. PubMed ID: 12556776
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Safety and tolerability of high-dose intravenous esomeprazole for prevention of peptic ulcer rebleeding.
    Kuipers EJ; Sung JJ; Barkun A; Mössner J; Jensen D; Stuart R; Lau JY; Ahlbom H; Lind T; Kilhamn J
    Adv Ther; 2011 Feb; 28(2):150-9. PubMed ID: 21181319
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Endoscopic hemostasis in peptic ulcer bleeding for patients with high-risk lesions: a series of meta-analyses.
    Barkun AN; Martel M; Toubouti Y; Rahme E; Bardou M
    Gastrointest Endosc; 2009 Apr; 69(4):786-99. PubMed ID: 19152905
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Intravenous non-high-dose pantoprazole is equally effective as high-dose pantoprazole in preventing rebleeding among low risk patients with a bleeding peptic ulcer after initial endoscopic hemostasis.
    Liang CM; Lee JH; Kuo YH; Wu KL; Chiu YC; Chou YP; Hu ML; Tai WC; Chiu KW; Hu TH; Chuah SK
    BMC Gastroenterol; 2012 Mar; 12():28. PubMed ID: 22455511
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Predictors of hemostatic failure after adrenaline injection in patients with peptic ulcers with non-bleeding visible vessel.
    Thomopoulos KC; Theocharis GJ; Vagenas KA; Danikas DD; Vagianos CE; Nikolopoulou VN
    Scand J Gastroenterol; 2004 Jun; 39(6):600-4. PubMed ID: 15223687
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effect of intravenous proton pump inhibitor regimens and timing of endoscopy on clinical outcomes of peptic ulcer bleeding.
    Liu N; Liu L; Zhang H; Gyawali PC; Zhang D; Yao L; Yang Y; Wu K; Ding J; Fan D
    J Gastroenterol Hepatol; 2012 Sep; 27(9):1473-9. PubMed ID: 22646140
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Intravenous omeprazole prevents rebleeding in peptic ulcer patients with a non-bleeding visible vessel: a preliminary report of a randomized controlled study.
    Chua RT; Lin HJ; Wang K; Perng CL; Lo WC; Lee CH; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Feb; 57(2):139-45. PubMed ID: 8634929
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Ulcers and nonvariceal bleeding.
    Church NI; Palmer KR
    Endoscopy; 2003 Jan; 35(1):22-6. PubMed ID: 12510222
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparison of Oral versus Intravenous Proton Pump Inhibitors in Preventing Re-bleeding from Peptic Ulcer after Successful Endoscopic Therapy.
    Karim R; Hameed R; Ali K; Tahir A
    Cureus; 2020 Jan; 12(1):e6741. PubMed ID: 32133263
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Timing of rebleeding in high-risk peptic ulcer bleeding after successful hemostasis: a systematic review.
    El Ouali S; Barkun A; Martel M; Maggio D
    Can J Gastroenterol Hepatol; 2014 Nov; 28(10):543-8. PubMed ID: 25390616
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effect of scheduled second therapeutic endoscopy on peptic ulcer rebleeding: a prospective randomised trial.
    Chiu PW; Lam CY; Lee SW; Kwong KH; Lam SH; Lee DT; Kwok SP
    Gut; 2003 Oct; 52(10):1403-7. PubMed ID: 12970130
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cost effectiveness of high-dose intravenous esomeprazole for peptic ulcer bleeding.
    Barkun AN; Adam V; Sung JJ; Kuipers EJ; Mössner J; Jensen D; Stuart R; Lau JY; Nauclér E; Kilhamn J; Granstedt H; Liljas B; Lind T
    Pharmacoeconomics; 2010; 28(3):217-30. PubMed ID: 20151726
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Intravenous Esomeprazole for Prevention of Peptic Ulcer Rebleeding: A Randomized Trial in Chinese Patients.
    Bai Y; Chen DF; Wang RQ; Chen YX; Shi RH; Tian DA; Chen H; Eklund S; Li ZS;
    Adv Ther; 2015 Nov; 32(11):1160-76. PubMed ID: 26581750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.